Advertisement

Index by author

July 01, 1984; Volume 230,Issue 1

A

  1. Adelman, W J

    1. Excitable channel currents and gating times in the presence of anticonvulsants ethosuximide and valproate.
      J F Fohlmeister, W J Adelman and J J Brennan
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 75-81;

  2. Ambrose, J M

    1. Effects of calcium antagonists and vasodilators on arterial myosin phosphorylation and actin-myosin interactions.
      P J Silver, J Dachiw and J M Ambrose
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 141-148;

  3. Appel, J B

    1. Discriminative stimulus properties of lergotrile.
      K A Cunningham, P M Callahan and J B Appel
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 47-52;

B

  1. Bahouth, S W

    1. Specific binding of a 125I-labeled substance P analog to rat submaxillary gland.
      S W Bahouth, J M Stewart and J M Musacchio
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 116-123;

  2. Barcas, P P

    1. Endogenous GABAergic mechanisms in the medulla and the regulation of blood pressure.
      R N Willette, P P Barcas, A J Krieger and H N Sapru
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 34-39;

  3. Baskin, E P

    1. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
      R J Winquist, P K Siegl, E P Baskin, D L Bohn, G Morgan and A A Wallace
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 103-109;

  4. Begenisich, T

    1. Determination of the active form of phenytoin.
      R S Morello, T Begenisich and J Z Yeh
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 156-161;

  5. Benowitz, N

    1. Efficacy and mechanism of action of sodium bicarbonate in the treatment of desipramine toxicity in rats.
      P Pentel and N Benowitz
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 12-19;

  6. Bergström, K

    1. Kinetics of 11C-labeled opiates in the brain of rhesus monkeys.
      P Hartvig, K Bergström, B Lindberg, P O Lundberg, H Lundqvist, B Långström, H Svärd and A Rane
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 250-255;

  7. Berlan, M

    1. Interplay of alpha-2 and beta adrenoceptors in the control of free fatty acid release from bone marrow adipose tissue.
      M A Tran, D T Lac, M Berlan and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 228-231;

  8. Boder, G B

    1. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
      J S Hayes, N Bowling, G B Boder and R Kauffman
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 124-132;

  9. Bohn, D L

    1. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
      R J Winquist, P K Siegl, E P Baskin, D L Bohn, G Morgan and A A Wallace
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 103-109;

  10. Bolt, G R

    1. Interaction of atenolol with the systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits.
      G R Bolt and P R Saxena
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 205-213;

  11. Bousquet, P

    1. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines.
      P Bousquet, J Feldman and J Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 232-236;

  12. Bowling, N

    1. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
      J S Hayes, N Bowling, G B Boder and R Kauffman
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 124-132;

  13. Branch, R A

    1. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
      A Küpfer, R Patwardhan, S Ward, S Schenker, R Preisig and R A Branch
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 28-33;

  14. Brennan, J J

    1. Excitable channel currents and gating times in the presence of anticonvulsants ethosuximide and valproate.
      J F Fohlmeister, W J Adelman and J J Brennan
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 75-81;

  15. Brown, D M

    1. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
      R G Knodell, B S Handwerger, J E Morley, A S Levine and D M Brown
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 256-262;

C

  1. Callahan, P M

    1. Discriminative stimulus properties of lergotrile.
      K A Cunningham, P M Callahan and J B Appel
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 47-52;

  2. Carter, R B

    1. Comparison of the effects of naloxone and picrotoxin on schedule-controlled responding in the pigeon: possible GABA-antagonistic effects of naloxone.
      R B Carter and J D Leander
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 40-46;

  3. Catto, B A

    1. Concentration-time course of niridazole and six metabolites in the serum of four Filipinos with Schistosoma japonicum infection.
      C I Valencia, B A Catto, E H Fairchild, S B Wilson, N C Maramba and L T Webster
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 133-140;

  4. Colpaert, F C

    1. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
      F C Colpaert and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 193-199;

  5. Cone, E J

    1. Phencyclidine analogs and precursors: rotarod and lethal dose studies in the mouse.
      D B Vaupel, D McCoun and E J Cone
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 20-27;

  6. Cory, R N

    1. Kinetic characterization of the rabbit aorta contractile response to an alpha adrenergic agonist.
      R N Cory, R Osman and S Maayani
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 162-170;

  7. Couet, W R

    1. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
      J A Waschek, G M Rubin, T N Tozer, R M Fielding, W R Couet, D J Effeney and S M Pond
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 89-93;

  8. Cowan, A

    1. In vivo evidence for benzomorphan-selective receptors in rats.
      D E Gmerek and A Cowan
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 110-115;

  9. Crews, F T

    1. Inhibition of immunoglobulin, but not polypeptide base-stimulated release of histamine and arachidonic acid by anti-inflammatory steroids.
      A S Heiman and F T Crews
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 175-182;

  10. Cunningham, K A

    1. Discriminative stimulus properties of lergotrile.
      K A Cunningham, P M Callahan and J B Appel
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 47-52;

D

  1. Dachiw, J

    1. Effects of calcium antagonists and vasodilators on arterial myosin phosphorylation and actin-myosin interactions.
      P J Silver, J Dachiw and J M Ambrose
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 141-148;

  2. Davies, S

    1. Ethanol suppresses hepatic glutathione synthesis in rats in vivo.
      B H Lauterburg, S Davies and J R Mitchell
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 7-11;

  3. Deupree, J D

    1. Inhibition of catecholamine transport into chromaffin granule ghosts isolated from bovine adrenal glands by phenytoin.
      J D Deupree, D A Downs, J E Laposky and J J Hitchcock
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 171-174;

  4. Dombro, K R

    1. Effect of erythrosin B on hyperpolarizing responses to catecholamines in amphibian sympathetic ganglia.
      P A Smith, K R Dombro and J Zidichouski
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 221-227;

  5. Downs, D A

    1. Inhibition of catecholamine transport into chromaffin granule ghosts isolated from bovine adrenal glands by phenytoin.
      J D Deupree, D A Downs, J E Laposky and J J Hitchcock
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 171-174;

  6. Dubocovich, M L

    1. Alpha-2 adrenoceptors modulate [3H]dopamine release from rabbit retina.
      M L Dubocovich
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 149-155;

E

  1. Effeney, D J

    1. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
      J A Waschek, G M Rubin, T N Tozer, R M Fielding, W R Couet, D J Effeney and S M Pond
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 89-93;

F

  1. Fairchild, E H

    1. Concentration-time course of niridazole and six metabolites in the serum of four Filipinos with Schistosoma japonicum infection.
      C I Valencia, B A Catto, E H Fairchild, S B Wilson, N C Maramba and L T Webster
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 133-140;

  2. Feldman, J

    1. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines.
      P Bousquet, J Feldman and J Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 232-236;

  3. Field, M J

    1. Effects of enantiomers of indacrinone (MK-196) on cation transport by the loop of Henle and distal tubule studied by microperfusion in vivo.
      M J Field, N Fowler and G H Giebisch
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 62-68;

  4. Fielding, R M

    1. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
      J A Waschek, G M Rubin, T N Tozer, R M Fielding, W R Couet, D J Effeney and S M Pond
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 89-93;

  5. Fohlmeister, J F

    1. Excitable channel currents and gating times in the presence of anticonvulsants ethosuximide and valproate.
      J F Fohlmeister, W J Adelman and J J Brennan
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 75-81;

  6. Fowler, N

    1. Effects of enantiomers of indacrinone (MK-196) on cation transport by the loop of Henle and distal tubule studied by microperfusion in vivo.
      M J Field, N Fowler and G H Giebisch
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 62-68;

G

  1. Giebisch, G H

    1. Effects of enantiomers of indacrinone (MK-196) on cation transport by the loop of Henle and distal tubule studied by microperfusion in vivo.
      M J Field, N Fowler and G H Giebisch
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 62-68;

  2. Giraud, G D

    1. Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation.
      G D Giraud and K L MacCannell
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 214-220;

  3. Gmerek, D E

    1. In vivo evidence for benzomorphan-selective receptors in rats.
      D E Gmerek and A Cowan
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 110-115;

H

  1. Handwerger, B S

    1. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
      R G Knodell, B S Handwerger, J E Morley, A S Levine and D M Brown
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 256-262;

  2. Hartvig, P

    1. Kinetics of 11C-labeled opiates in the brain of rhesus monkeys.
      P Hartvig, K Bergström, B Lindberg, P O Lundberg, H Lundqvist, B Långström, H Svärd and A Rane
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 250-255;

  3. Hayes, J S

    1. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
      J S Hayes, N Bowling, G B Boder and R Kauffman
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 124-132;

  4. Heiman, A S

    1. Inhibition of immunoglobulin, but not polypeptide base-stimulated release of histamine and arachidonic acid by anti-inflammatory steroids.
      A S Heiman and F T Crews
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 175-182;

  5. Herz, A

    1. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
      R Schulz, M Wüster and A Herz
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 200-204;

  6. Hitchcock, J J

    1. Inhibition of catecholamine transport into chromaffin granule ghosts isolated from bovine adrenal glands by phenytoin.
      J D Deupree, D A Downs, J E Laposky and J J Hitchcock
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 171-174;

J

  1. Janssen, P A

    1. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
      F C Colpaert and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 193-199;

K

  1. Kauffman, R

    1. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
      J S Hayes, N Bowling, G B Boder and R Kauffman
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 124-132;

  2. Knodell, R G

    1. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
      R G Knodell, B S Handwerger, J E Morley, A S Levine and D M Brown
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 256-262;

  3. Krieger, A J

    1. Endogenous GABAergic mechanisms in the medulla and the regulation of blood pressure.
      R N Willette, P P Barcas, A J Krieger and H N Sapru
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 34-39;

  4. Küpfer, A

    1. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
      A Küpfer, R Patwardhan, S Ward, S Schenker, R Preisig and R A Branch
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 28-33;

L

  1. Lac, D T

    1. Interplay of alpha-2 and beta adrenoceptors in the control of free fatty acid release from bone marrow adipose tissue.
      M A Tran, D T Lac, M Berlan and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 228-231;

  2. Lafontan, M

    1. Interplay of alpha-2 and beta adrenoceptors in the control of free fatty acid release from bone marrow adipose tissue.
      M A Tran, D T Lac, M Berlan and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 228-231;

  3. Lakin, M L

    1. Effects of amine pretreatment on ketamine catatonia in pinealectomized or hypophysectomized animals.
      W D Winters, J P Petit, M L Lakin and C H Miller
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 69-74;

  4. Långström, B

    1. Kinetics of 11C-labeled opiates in the brain of rhesus monkeys.
      P Hartvig, K Bergström, B Lindberg, P O Lundberg, H Lundqvist, B Långström, H Svärd and A Rane
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 250-255;

  5. Laposky, J E

    1. Inhibition of catecholamine transport into chromaffin granule ghosts isolated from bovine adrenal glands by phenytoin.
      J D Deupree, D A Downs, J E Laposky and J J Hitchcock
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 171-174;

  6. Latifpour, J

    1. Cardiac autonomic receptors: effect of long-term experimental diabetes.
      J Latifpour and J H McNeill
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 242-249;

  7. Lauterburg, B H

    1. Ethanol suppresses hepatic glutathione synthesis in rats in vivo.
      B H Lauterburg, S Davies and J R Mitchell
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 7-11;

  8. Leander, J D

    1. Comparison of the effects of naloxone and picrotoxin on schedule-controlled responding in the pigeon: possible GABA-antagonistic effects of naloxone.
      R B Carter and J D Leander
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 40-46;

  9. Levine, A S

    1. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
      R G Knodell, B S Handwerger, J E Morley, A S Levine and D M Brown
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 256-262;

  10. Lindberg, B

    1. Kinetics of 11C-labeled opiates in the brain of rhesus monkeys.
      P Hartvig, K Bergström, B Lindberg, P O Lundberg, H Lundqvist, B Långström, H Svärd and A Rane
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 250-255;

  11. Lundberg, P O

    1. Kinetics of 11C-labeled opiates in the brain of rhesus monkeys.
      P Hartvig, K Bergström, B Lindberg, P O Lundberg, H Lundqvist, B Långström, H Svärd and A Rane
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 250-255;

  12. Lundqvist, H

    1. Kinetics of 11C-labeled opiates in the brain of rhesus monkeys.
      P Hartvig, K Bergström, B Lindberg, P O Lundberg, H Lundqvist, B Långström, H Svärd and A Rane
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 250-255;

M

  1. Maayani, S

    1. Kinetic characterization of the rabbit aorta contractile response to an alpha adrenergic agonist.
      R N Cory, R Osman and S Maayani
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 162-170;

  2. MacCannell, K L

    1. Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation.
      G D Giraud and K L MacCannell
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 214-220;

  3. Macdonald, R L

    1. Multiple actions of convulsant barbiturates on mouse neurons in cell culture.
      J H Skerritt and R L Macdonald
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 82-88;

  4. Maramba, N C

    1. Concentration-time course of niridazole and six metabolites in the serum of four Filipinos with Schistosoma japonicum infection.
      C I Valencia, B A Catto, E H Fairchild, S B Wilson, N C Maramba and L T Webster
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 133-140;

  5. McCoun, D

    1. Phencyclidine analogs and precursors: rotarod and lethal dose studies in the mouse.
      D B Vaupel, D McCoun and E J Cone
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 20-27;

  6. McNeill, J H

    1. Cardiac autonomic receptors: effect of long-term experimental diabetes.
      J Latifpour and J H McNeill
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 242-249;

  7. Meffin, P J

    1. Diisopropylfluorophosphate increases clofibric acid clearance: supporting evidence for a futile cycle.
      B J Rowe and P J Meffin
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 237-241;

  8. Miller, C H

    1. Effects of amine pretreatment on ketamine catatonia in pinealectomized or hypophysectomized animals.
      W D Winters, J P Petit, M L Lakin and C H Miller
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 69-74;

  9. Mitchell, J R

    1. Ethanol suppresses hepatic glutathione synthesis in rats in vivo.
      B H Lauterburg, S Davies and J R Mitchell
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 7-11;

  10. Morello, R S

    1. Determination of the active form of phenytoin.
      R S Morello, T Begenisich and J Z Yeh
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 156-161;

  11. Morgan, G

    1. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
      R J Winquist, P K Siegl, E P Baskin, D L Bohn, G Morgan and A A Wallace
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 103-109;

  12. Morley, J E

    1. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
      R G Knodell, B S Handwerger, J E Morley, A S Levine and D M Brown
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 256-262;

  13. Munson, A E

    1. Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro.
      V M Sanders and A E Munson
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 183-192;

  14. Musacchio, J M

    1. Specific binding of a 125I-labeled substance P analog to rat submaxillary gland.
      S W Bahouth, J M Stewart and J M Musacchio
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 116-123;

N

  1. Nelson, A

    1. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro.
      E Richelson and A Nelson
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 94-102;

O

  1. Osman, R

    1. Kinetic characterization of the rabbit aorta contractile response to an alpha adrenergic agonist.
      R N Cory, R Osman and S Maayani
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 162-170;

P

  1. Pang, P K

    1. Direct effect of parathyroid hormone on rat uterine contraction.
      R L Shew, J A Yee and P K Pang
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 1-6;

  2. Patwardhan, R

    1. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
      A Küpfer, R Patwardhan, S Ward, S Schenker, R Preisig and R A Branch
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 28-33;

  3. Pentel, P

    1. Efficacy and mechanism of action of sodium bicarbonate in the treatment of desipramine toxicity in rats.
      P Pentel and N Benowitz
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 12-19;

  4. Petit, J P

    1. Effects of amine pretreatment on ketamine catatonia in pinealectomized or hypophysectomized animals.
      W D Winters, J P Petit, M L Lakin and C H Miller
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 69-74;

  5. Pond, S M

    1. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
      J A Waschek, G M Rubin, T N Tozer, R M Fielding, W R Couet, D J Effeney and S M Pond
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 89-93;

  6. Preisig, R

    1. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
      A Küpfer, R Patwardhan, S Ward, S Schenker, R Preisig and R A Branch
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 28-33;

R

  1. Rane, A

    1. Kinetics of 11C-labeled opiates in the brain of rhesus monkeys.
      P Hartvig, K Bergström, B Lindberg, P O Lundberg, H Lundqvist, B Långström, H Svärd and A Rane
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 250-255;

  2. Richelson, E

    1. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro.
      E Richelson and A Nelson
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 94-102;

  3. Rowe, B J

    1. Diisopropylfluorophosphate increases clofibric acid clearance: supporting evidence for a futile cycle.
      B J Rowe and P J Meffin
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 237-241;

  4. Rubin, G M

    1. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
      J A Waschek, G M Rubin, T N Tozer, R M Fielding, W R Couet, D J Effeney and S M Pond
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 89-93;

S

  1. Sanders, V M

    1. Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro.
      V M Sanders and A E Munson
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 183-192;

  2. Sapru, H N

    1. Endogenous GABAergic mechanisms in the medulla and the regulation of blood pressure.
      R N Willette, P P Barcas, A J Krieger and H N Sapru
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 34-39;

  3. Saxena, P R

    1. Interaction of atenolol with the systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits.
      G R Bolt and P R Saxena
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 205-213;

  4. Schenker, S

    1. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
      A Küpfer, R Patwardhan, S Ward, S Schenker, R Preisig and R A Branch
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 28-33;

  5. Schulz, R

    1. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
      R Schulz, M Wüster and A Herz
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 200-204;

  6. Schwartz, J

    1. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines.
      P Bousquet, J Feldman and J Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 232-236;

  7. Shew, R L

    1. Direct effect of parathyroid hormone on rat uterine contraction.
      R L Shew, J A Yee and P K Pang
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 1-6;

  8. Siegl, P K

    1. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
      R J Winquist, P K Siegl, E P Baskin, D L Bohn, G Morgan and A A Wallace
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 103-109;

  9. Silver, P J

    1. Effects of calcium antagonists and vasodilators on arterial myosin phosphorylation and actin-myosin interactions.
      P J Silver, J Dachiw and J M Ambrose
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 141-148;

  10. Skerritt, J H

    1. Multiple actions of convulsant barbiturates on mouse neurons in cell culture.
      J H Skerritt and R L Macdonald
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 82-88;

  11. Slepetis, R J

    1. Obligatory role of thyroid hormones in development of peripheral sympathetic and central nervous system catecholaminergic neurons: effects of propylthiouracil-induced hypothyroidism on transmitter levels, turnover and release.
      T A Slotkin and R J Slepetis
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 53-61;

  12. Slotkin, T A

    1. Obligatory role of thyroid hormones in development of peripheral sympathetic and central nervous system catecholaminergic neurons: effects of propylthiouracil-induced hypothyroidism on transmitter levels, turnover and release.
      T A Slotkin and R J Slepetis
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 53-61;

  13. Smith, P A

    1. Effect of erythrosin B on hyperpolarizing responses to catecholamines in amphibian sympathetic ganglia.
      P A Smith, K R Dombro and J Zidichouski
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 221-227;

  14. Stewart, J M

    1. Specific binding of a 125I-labeled substance P analog to rat submaxillary gland.
      S W Bahouth, J M Stewart and J M Musacchio
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 116-123;

  15. Svärd, H

    1. Kinetics of 11C-labeled opiates in the brain of rhesus monkeys.
      P Hartvig, K Bergström, B Lindberg, P O Lundberg, H Lundqvist, B Långström, H Svärd and A Rane
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 250-255;

T

  1. Tozer, T N

    1. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
      J A Waschek, G M Rubin, T N Tozer, R M Fielding, W R Couet, D J Effeney and S M Pond
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 89-93;

  2. Tran, M A

    1. Interplay of alpha-2 and beta adrenoceptors in the control of free fatty acid release from bone marrow adipose tissue.
      M A Tran, D T Lac, M Berlan and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 228-231;

V

  1. Valencia, C I

    1. Concentration-time course of niridazole and six metabolites in the serum of four Filipinos with Schistosoma japonicum infection.
      C I Valencia, B A Catto, E H Fairchild, S B Wilson, N C Maramba and L T Webster
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 133-140;

  2. Vaupel, D B

    1. Phencyclidine analogs and precursors: rotarod and lethal dose studies in the mouse.
      D B Vaupel, D McCoun and E J Cone
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 20-27;

W

  1. Wallace, A A

    1. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
      R J Winquist, P K Siegl, E P Baskin, D L Bohn, G Morgan and A A Wallace
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 103-109;

  2. Ward, S

    1. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
      A Küpfer, R Patwardhan, S Ward, S Schenker, R Preisig and R A Branch
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 28-33;

  3. Waschek, J A

    1. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
      J A Waschek, G M Rubin, T N Tozer, R M Fielding, W R Couet, D J Effeney and S M Pond
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 89-93;

  4. Webster, L T

    1. Concentration-time course of niridazole and six metabolites in the serum of four Filipinos with Schistosoma japonicum infection.
      C I Valencia, B A Catto, E H Fairchild, S B Wilson, N C Maramba and L T Webster
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 133-140;

  5. Willette, R N

    1. Endogenous GABAergic mechanisms in the medulla and the regulation of blood pressure.
      R N Willette, P P Barcas, A J Krieger and H N Sapru
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 34-39;

  6. Wilson, S B

    1. Concentration-time course of niridazole and six metabolites in the serum of four Filipinos with Schistosoma japonicum infection.
      C I Valencia, B A Catto, E H Fairchild, S B Wilson, N C Maramba and L T Webster
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 133-140;

  7. Winquist, R J

    1. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
      R J Winquist, P K Siegl, E P Baskin, D L Bohn, G Morgan and A A Wallace
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 103-109;

  8. Winters, W D

    1. Effects of amine pretreatment on ketamine catatonia in pinealectomized or hypophysectomized animals.
      W D Winters, J P Petit, M L Lakin and C H Miller
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 69-74;

  9. Wüster, M

    1. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
      R Schulz, M Wüster and A Herz
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 200-204;

Y

  1. Yee, J A

    1. Direct effect of parathyroid hormone on rat uterine contraction.
      R L Shew, J A Yee and P K Pang
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 1-6;

  2. Yeh, J Z

    1. Determination of the active form of phenytoin.
      R S Morello, T Begenisich and J Z Yeh
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 156-161;

Z

  1. Zidichouski, J

    1. Effect of erythrosin B on hyperpolarizing responses to catecholamines in amphibian sympathetic ganglia.
      P A Smith, K R Dombro and J Zidichouski
      Journal of Pharmacology and Experimental Therapeutics July 1984, 230 (1) 221-227;
Back to top

In this issue

Advertisement